logo

For the Inventor, By the Inventor

Palaiseau, France

Thierry Gallet

This inventor holds 13 USPTO granted patents and 2 EPO patents. Top assignees: Sanofi-Aventis, Mitsubishi Pharma Corporation, Mitsubishi Tanabe Pharma Corporation. Active years: 2000-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thierry Gallet. Retrieved from https://idiyas.com/inventor/thierry-gallet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13

% Patents Active = 46.2

 

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Paris, FR (2012)
  • Palaiseau, FR (2000 - 2013)

Company Filing History:

goldMedal8 out of 390 
 
Sanofi-Aventis
 patents
silverMedal6 out of 73 
 
Mitsubishi Pharma Corporation
 patents
bronzeMedal2 out of 263 
 
Mitsubishi Tanabe Pharma Corporation
 patents
4. 2 out of 1,549 
 
Sanofi
 patents
5. 2 out of 152 
 
Sanofi-Synthelabo
 patents
6. 1 out of 1 
 
Sanotl-Aventis
 patent
7. 1 out of 7 
 
Tanabe Pharma Corporation
 patents
where one patent can have more than one assignee

Years Active: 2000-2013

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 8598175 - Heteroarylamide pyrimidone derivatives (2013-12-03),
2. 8592436 - Arylamide pyrimidone derivatives (2013-11-26),
3. 8198287 - Substituted heteroaryl pyridopyrimidone derivatives (2012-06-12),
4. 7781440 - [object Object] (2010-08-24),
5. 7566720 - [object Object] (2009-07-28),
6. 7462621 - Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agents (2008-12-09),
7. 7388005 - Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders (2008-06-17),
8. 7214682 - Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives (2007-05-08),
9. 7001902 - 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof (2006-02-21),
10. 6987106 - 1,4-diazabicyclo[3.2.2]nonane-4-carboxylates and carboxamide derivates, production and use thereof in therapeutics (2006-01-17),
11. 6974819 - 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo{1,2-a}pyrimidin-5(1H)one derivatives (2005-12-13),
12. 6255319 - 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands (2001-07-03),
13. 6143761 - 2,3-dihydrofuro [3,2-.beta.]pyridin, preparation and application thereof (2000-11-07),

Title: Innovations of Thierry Gallet

Introduction

Thierry Gallet is a prominent inventor based in Palaiseau, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the Heteroarylamide pyrimidone derivatives. This invention discloses a series of pyrimidone derivatives represented by a specific formula, along with their salts, solvates, and hydrates. The invention also details methods for preparing these compounds and their utility in treating various disease conditions. Another notable patent is for Arylamide pyrimidone derivatives, which similarly outlines a series of pyrimidone derivatives and their potential applications in medicine.

Career Highlights

Thierry Gallet has worked with notable companies in the pharmaceutical industry, including Sanofi-Aventis and Mitsubishi Pharma Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Thierry has collaborated with several professionals in his field, including Alistair Lochead and Mourad Saady. These collaborations have likely enhanced his research and development efforts.

Conclusion

Thierry Gallet's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…